# Efficacy and Safety Eval of Guanfacine Hydrochloride in Combination With Psychostimulants in Adults (18-65).

> **NCT02141113** · PHASE4 · COMPLETED · sponsor: **Rochester Center for Behavioral Medicine** · enrollment: 26 (actual)

## Conditions studied

- Adult Attention-Deficit Hyperactivity Disorder

## Interventions

- **DRUG:** Guanfacine Hydrochloride
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02141113
- **Lead sponsor:** Rochester Center for Behavioral Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11
- **Primary completion:** 2014-09
- **Final completion:** 2014-11
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2025-08-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02141113

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02141113, "Efficacy and Safety Eval of Guanfacine Hydrochloride in Combination With Psychostimulants in Adults (18-65).". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT02141113. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*